BDBM771760 3-[[(2R)-1- acetylazetidin-2- yl]methyl]-2-[[4- [2-(4-chloro-2- fluoro-phenyl)-2- methyl-1,3- benzodioxol-4-yl]- 2-fluoro- phenyl]methyl] benzimidazole-5- carboxylic acid::US20250099431, Example 108

SMILES CC(=O)N1CC[C@@H]1Cn1c(Cc2ccc(-c3cccc4c3OC(C)(c3ccc(Cl)cc3F)O4)cc2F)nc2ccc(C(=O)O)cc21

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 771760   

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771760(3-[[(2R)-1- acetylazetidin-2- yl]methyl]-2-[[4- [2...)
Affinity DataEC50:  4.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent